15 Results for "

GPR55 agonist

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "GPR55 agonist" in MCE Product Catalog:

26
26 Cited Publications
Cat. No.: HY-15443
CAS No.: 183232-66-8
Purity:  99.09%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

AM251 is a selective cannabinoid 1 (CB1) receptor antagonist with an IC50 of 8 nM. AM251 also acts as a potent GPR55 agonist with an EC50 of 39 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-107541
CAS No.: 317321-41-8
Purity:  99.68%
Target:  

GPR55

Research Areas:  

Neurological Disease

O-1602 is an agonist of GPR55 (G protein-coupled receptor 55). O-1602 reduces the number and activation of hippocampal microglia induced by METH (methamphetamine). O-1602 decreases the expression levels of NLRP3 inflammasome proteins, including NLRP3, ASC and Caspase-1 .
loading...
    loading...
Cat. No.: HY-116637
CAS No.: 20601-85-8
Purity:  99.79%
Synonyms: Magnolignan
Tetrahydromagnolol (Magnolignan), the main metabolite of Magnolol, is a potent and selective cannabinoidCB2 receptor agonist (EC50 =170 nM) and GPR55 antagonist. The Ki of Tetrahydromagnolol for CB2 is 416 nM, 20-fold higher than for the CB1 receptor. Magnolol shows antifungal, anti-inflammatory and analgesic effects .
loading...
    loading...
Cat. No.: HY-156157
CAS No.: 3006105-55-8
Purity:  98.36%
Target:  

GPR55

Research Areas:  

Cancer

GPR55 agonist 4 (Compound 28) is a GPR55 agonist (EC50: 131 nM, and 1.41 nM for hGPR55 and rGPR55). GPR55 agonist 4 induces β-arrestin recruitment to human GPR55 .
loading...
    loading...
Cat. No.: HY-156107
CAS No.: 3006105-44-5
Purity:  99.17%
Target:  

GPR55

Research Areas:  

Cancer

GPR55 agonist 3 (Compound 26) is a GPR55 agonist (EC50: 0.239 nM, and 1.76 nM for hGPR55 and rGPR55). GPR55 agonist 3 induces β-arrestin recruitment to human GPR55 (EC50: 6.2 nM) .
loading...
    loading...
Cat. No.: HY-116461
CAS No.: 794572-10-4
Purity:  99.57%
Synonyms: CID2440433
Target:  

GPR55

Research Areas:  

Neurological Disease

ML-184 (CID244033) is a selective GPR55 agonist with an EC50 of 250 nM, more than 100-fold selectivity for GPR55 over GPR35, CB1, and CB2. ML-184 induces ERK1/2 phosphorylation and PKCβII translocation to the plasma membrane via activation of GPR55. ML-184 (CID2440433) increases the proliferation of neural stem cells and promotes neuronal differentiation in vitro .
loading...
    loading...
Cat. No.: HY-162618
CAS No.: 885896-54-8
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

PSB-KK1445 is a potent and selective GPR18 agonist with EC50s of 45.4 nM and 124 nM for human and mouse GPR18, respectively. PSB-KK1445 displays >200-fold selectivity versus both CB receptor subtypes, GPR55, and GPR183 .
loading...
    loading...
Cat. No.: HY-125111
CAS No.: 1399049-81-0
Purity:  99.36%
PSB-SB-487 is a potent GPR55 antagonist and CB2 agonist with an IC50 value of 0.113 µM for GPR55, and a Ki value of 0.292 µM for human CB2. PSB-SB-487 can be used for researching diabetes, Parkinson’s disease, neuropathic pain, and cancer .
loading...
    loading...
Cat. No.: HY-103336
CAS No.: 1186195-59-4
Synonyms: T1117
Research Areas:  

Cancer

Tocrifluor 1117 is a selective GPR55 ligand and fluorescent probe. Tocrifluor 1117 shows extremely low affinity for mouse CB1 receptors (Ki >1000 nM) and only weakly displaces CB1 agonists. Tocrifluor 1117 specifically activates GPR55 to trigger intracellular calcium oscillations, and binds to vascular smooth muscle, endothelial and adventitial cells; all these binding effects are inhibited by pretreatment with unlabeled AM251 or O1602. Tocrifluor 1117 can clearly visualize the distribution of GPR55 in vascular tissues via confocal microscopy, while its uptake in cancer cells is completely dependent on GPR55 expression .
loading...
    loading...
Cat. No.: HY-123302
CAS No.: 459848-10-3
Target:  

GPR55

Research Areas:  

Neurological Disease

CID1172084 (compound 3) is a selective GPR55 agonist (EC50=0.16 μM). CID1172084 is more than 100-fold selective for GPR55 over GPR35, CB1, and CB2. CID1172084 can be used to further explore the biological functions and signaling pathways of the GPR55 receptor .
loading...
    loading...
Cat. No.: HY-168997
CB1R agonist 1 is a potent, CNS-penetrant, and selective Cannabinoid-1 receptor (CB1R) agonist with a Ki of 0.95 nM, modulating Gi/o signaling. CB1R agonist 1 exhibits high selectivity over CB2R and other off-target GPCRs, including GPR55, GPR18, and GPR119. CB1R agonist 1 induces analgesia and hypothermia, and potentiates opioid analgesia in mice. CB1R agonist 1 can be used for the research of pain .
loading...
    loading...
Cat. No.: HY-114954
CAS No.: 1164479-69-9
Target:  

GPR55

CID1792197 is a GPR55 agonist with an EC50 value of 0.11 μM .
loading...
    loading...
Cat. No.: HY-15443R
CAS No.: 183232-66-8
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

AM251 (Standard) is the analytical standard of AM251. This product is intended for research and analytical applications. AM251 is a selective cannabinoid 1 (CB1) receptor antagonist with an IC50 of 8 nM. AM251 also acts as a potent GPR55 agonist with an EC50 of 39 nM .
loading...
    loading...
Cat. No.: HY-107541R
CAS No.: 317321-41-8
Research Areas:  

Neurological Disease

O-1602 (Standard) is the analytical standard of O-1602. This product is intended for research and analytical applications. O-1602 is an agonist of GPR55 (G protein-coupled receptor 55). O-1602 reduces the number and activation of hippocampal microglia induced by METH (methamphetamine). O-1602 decreases the expression levels of NLRP3 inflammasome proteins, including NLRP3, ASC and Caspase-1 .
loading...
    loading...
Cat. No.: HY-W1058476
CAS No.: 1443367-20-1
Target:  

GPR35 GPR55 Arrestin

Research Areas:  

Inflammation/Immunology Cancer

GPR35 agonist 6 is a potent and selective agonist targeting GPR35, with an EC50 of 12.1 nM against human GPR35. GPR35 agonist 6 activates the human splice variant GPR35b with comparable efficacy, showing an EC50 of 22.1 nM. GPR35 agonist 6 also exhibits weak GPR55 antagonistic activity, with an IC50 of 21.7 μM, and its agonistic activity towards GPR35 is significantly stronger than its antagonistic activity towards GPR55. GPR35 agonist 6 initiates GPR35 downstream signaling by inducing β-arrestin recruitment. GPR35 agonist 6 is used to investigate GPR35-mediated diseases, such as gastrointestinal lesions and gastric cancer .
loading...
    loading...
  • 1